G/O Media is once again attempting to use AI to churn out content — while simultaneously warning that anything the AI ...

The trend caught the attention of Novo Nordisk, the manufacturer of Ozempic ... and taking these drugs can be risky if you don’t have a high-quality protein diet. “I think Floridians are ...

The state’s effort to manufacture insulin is “getting at the underlying cost, which is the true sustainable solution to high-cost pharmaceuticals ... Eli Lilly, Novo Nordisk and Sanofi ...

The company has secured $410m in an oversubscribed Series A funding round, co-led by Forbion and General Atlantic, with contributions from investors such as RA Capital Management, OrbiMed, Logos ...

Diageo, the spirits company behind brands such as Johnnie Walker and Guinness, has had a torrid couple of years – the shares at £25.14 are 39% lower than their record high of £41.04 ... the likes of ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

However, on January 24, Jefferies maintained a Sell rating on Novo Nordisk (LSE: 0QIU). The company has a one-year high of DKK1,032.20 and a one-year low of DKK527.60. Currently, Novo Nordisk has ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable. In the Phase IIIb STEP UP trial, 7.2mg Wegovy demonstrated statistically ...

Novo Nordisk announced phase 1b/2a clinical trial results for amycretin this morning. Patients taking the GLP-1 drug lost an average of 9.7% of their weight in 36 weeks. This is the best news Novo ...